Relative Bioavailability of BI 201335 Capsule Versus Three Different Oral Solutions

NCT01764945 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 201335 (Reference)
DRUG: BI 201335 (Test)
DRUG: BI 201335 (Test)
DRUG: BI 201335 (Test)
DRUG: BI 201335 (Reference)
DRUG: BI 201335 (Test)
DRUG: BI 201335 (Test)
DRUG: BI 201335 (Test)

Sponsor

Boehringer Ingelheim